Top news
Stored first · Google News · Yahoo Finance (English)
- Pulse 2.02026. 07. 14. 20:48
Edgewise Therapeutics Completes $2.65 Billion Deal Of Sevasemten To Servier - Pulse 2.0
Edgewise Therapeutics Completes $2.65 Billion Deal Of Sevasemten To Servier Pulse 2.0
- GuruFocus2026. 07. 13. 23:04
Positive Trial Results Propel Edgewise's (EWTX) Plans for Phase 3 Development - GuruFocus
Positive Trial Results Propel Edgewise's (EWTX) Plans for Phase 3 Development GuruFocus
- citybiz2026. 07. 13. 22:56
Edgewise Therapeutics Completes Up to $2.65 Billion Sevasemten Sale to Focus on Cardiovascular Pipeline - citybiz
Edgewise Therapeutics Completes Up to $2.65 Billion Sevasemten Sale to Focus on Cardiovascular Pipeline citybiz
- PR Newswire2026. 07. 13. 21:30
Edgewise Therapeutics Completes Sale of Sevasemten for Up to $2.65 Billion, Strengthening Balance Sheet and Centering Company Focus on Cardiovascular Pipeline
- CNW Group2026. 07. 13. 21:30
Servier completes the acquisition of Edgewise Therapeutics' Muscular Dystrophy Business
- MT Newswires2026. 07. 10. 00:17
Edgewise Therapeutics' EDG-7500 Seen Entering 'Catalyst-Dense' Regulatory Period, Oppenheimer Says
